Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada

By De Wals P.   Petit G.   Erickson L.J.   Guay M.   Tam T.   Law B.   Framarin A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3757-3764

Elsevier

Access to resources Recommend Favorite

A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers

By Blum M.D.   Dagan R.   Mendelman P.M.   Pinsk V.   Giordani M.   Li S.   Bohidar N.   McNeely T.B.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2359-2367

Elsevier

Access to resources Recommend Favorite

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

By Jodar L.   Butler J.   Carlone G.   Dagan R.   Goldblatt D.   Kayhty H.   Klugman K.   Plikaytis B.   Siber G.   Kohberger R.   Chang I.   Cherian T.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3265-3272

Elsevier

Access to resources Recommend Favorite

Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy

By Esposito S.   Madore D.V.   Gironi S.   Bosis S.   Tosi S.   Bianchi C.   Cimino C.   Principi N.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2704-2707

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants

By Zangwill K.M.   Greenberg D.P.   Chiu C.-Y.   Mendelman P.   Wong V.K.   Chang S.-J.   Partridge S.   Ward J.I.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1894-1900

Elsevier

Access to resources Recommend Favorite